By Hinnerk Feldwisch-Drentrup in

As Bernd Heinemann, Chairman of Barmer's Board of Directors, observes that past efforts failed to counter the supply bottlenecks and he calls for storage obligations for pharmaceutical manufacturers. In addition, the law should impose penalties in case supply bottlenecks would not be reported.

Read the full article here .